Proof of Usefulness Report

Genpact

Analysis completed on 2/10/2026

+512
Proof of Usefulness Score
Industry Mainstay

The project represents Genpact (NYSE: G), a major global professional services firm, specifically its Pharmalink regulatory affairs division. While the real-world utility and traction of the underlying entity are immense (billions in revenue, global reach), the submission itself is of extremely low quality (persona 'WhisperHeart', claims like 'most people have used my product', and inaccurate revenue data). The score reflects the massive verified scale of the business, heavily penalized for the spam-like quality of the input data.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+213
Audience Reach Impact+90
Technical Innovation+23
Evidence Of Traction+180
Market Timing Relevance+60
Functional Completeness+3
Subtotal+569
Usefulness Multiplierx0.90
Final Score+512

Project Details

Project URL
genpact.com
Description
Life sciences companies are facing stringent regulatory requirements in developed markets and the challenge of satisfying dramatically variable requirements in emerging markets, resulting in penalties for non-compliance and costly delays. Genpact Pharmalink works with leading life sciences organizations including 9 of the top 10, helping their regulatory affairs affairs functions cut time-to-market, boost efficiency and ensure compliance to deliver superior patient and business value.

Algorithm Insights

Market Position
Strong market validation with clear user adoption patterns
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline